Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Gävle
Clinical trial register · Sweden

Clinical Trials in Gävle, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Sweden and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2219 matching records held by the registry are in this view. Synced 12 Oct 2026, 03:19 UTC
2219
Studies in scope
all four open statuses
1247
Recruiting now
open to new participants
367
Lead sponsors
across recruiting studies
Top sites
Stockholm 930 Gothenburg 631 Lund 404 Uppsala 369 Linköping 236
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Uppsala University5 Karolinska Institutet3 Region Gävleborg3 University of Gavle3 Lund University Hospital3
Site location
Stockholm930 Gothenburg631 Lund404 Uppsala369 Linköping236
All 146 locations
Target enrolment
to

Trials with a site in Gävle

53 of 2219 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Sweden
Start
Recruiting
The HIt HArd and hiT Early in Multiple Sclerosis Trial
NCT07517185Relapsing-remitting Multiple Sclerosis
Uppsala University
Phase 2
60
Falun, Gävle, Karlstad, Uppsala
2026-09-01
Not yet open
University of Gavle
Not applicable
180
Gävle
2026-06-01
Not yet open
University of Gavle
Observational
190
Gävle
2026-04-25
Recruiting
Aspects of Adjuvant CDK4/6 Inhibitors in Older Breast Cancer Patients - Focusing on Geriatric Screening
NCT07273357Geriatric Assessment, Adjuvant Drug Therapy, Breast Cancer Early Stage Breast Cancer (Stage 1-3)
Region Jönköping County
Observational
200
Gävle, Jönköping, Kalmar, Linköping, Örebro
2026-04-01
Not yet open
Elderly Care in Transition - the Older Persons' and the Staff's Perspective
NCT07504159Older People With Home Care, Staff Working With Older People in Home Care
University of Gavle
Observational
1,980
Gävle
2026-04-01
Not yet open
Region Gävleborg
Observational
75
Gävle
2026-04
Recruiting
Bristol-Myers Squibb
Phase 3
850
Gävle, Solna, Uppsala
2026-03-16
Recruiting
Bristol-Myers Squibb
Phase 3
750
Stockholm, Gävle
2026-03-12
Recruiting
University Hospital, Linkoeping
Not applicable
600
Gävle, Jönköping, Kalmar, Katrineholm, Kungsbacka, Linköping, Örebro
2026-01-27
Recruiting
Boehringer Ingelheim
Phase 3
670
Gävle, Gothenburg, Stockholm
2025-11-07
Recruiting
Pfizer
Phase 3
680
Gävle, Eskilstuna, Gothenburg
2025-09-29
Recruiting
Region Gävleborg
Observational
20
Gävle
2025-07-22
Recruiting
Eikon Therapeutics
Phase 2/3
740
Gävle, Stockholm
2025-05-22
Not yet open
Region Örebro County
Phase 3
3,832
Visby, Eskilstuna, Falun, Gävle, Gothenburg, Jönköping, Kalmar, Lund
2025-05-02
Recruiting
Improved Treatment for Patients With Long-term Opioid Therapy for Non-cancer Pain in Primary Care
NCT06856733Chronic Pain, Chronic Pain Management, Primary Care
Uppsala County Council, Sweden
Not applicable
110
Gävle, Strängnäs, Uppsala, Örebro
2025-03-10
Recruiting
Karolinska Institutet
Not applicable
1,000
Gävle, Halmstad, Linköping, Malmö, Umeå, Västerås
2025-03-03
Recruiting
Lomustine in Addition to Standard of Care in Patients With MGMT Methylated Glioblastoma
NCT06419946Glioblastoma, IDH-wildtype, MGMT-Methylated Glioblastoma
DrugsLomustine·Temozolomide
Vastra Gotaland Region
Phase 3
200
Gävle, Gothenburg, Jönköping, Kalmar, Lund, Örebro, Stockholm, Sundsvall
2025-02-01
Active, closed
Pfizer
Phase 3
1,035
Gävle, Stockholm, Uppsala, Västerås, Jönköping
2025-01-06
Recruiting
Uppsala University
Phase 3
1,792
Eskilstuna, Falun, Gävle, Gothenburg, Jönköping, Kalmar, Karlstad, Linköping
2024-12-19
Active, closed
Hoffmann-La Roche
Phase 3
338
Gävle
2024-09-23
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,530
Gävle, Stockholm, Uppsala, Borås, Gothenburg
2024-06-24
Active, closed
GlaxoSmithKline
Phase 3
88
Gävle
2024-06-10
Active, closed
AstraZeneca
Phase 3
2,554
Gävle, Gothenburg, Linköping, Rättvik, Stockholm, Uppsala
2024-03-29
Recruiting
Lund University Hospital
Phase 3
308
Gävle, Gothenburg, Jönköping, Karlstad, Linköping, Lund, Örebro, Stockholm
2024-03-04
Recruiting
Amgen
Phase 3
750
Gävle, Gothenburg, Umeå
2023-11-16
Recruiting
DESTINY Breast Respond HER2-(Ultra)Low Europe
NCT05945732Unresectable Breast Cancer, Metastatic Breast Cancer, HER2-low Expressing Breast Cancer, HER2-(Ultra)Low Expressing Breast Cancer
DrugTrastuzumab deruxtecan
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Observational
2,295
Eskilstuna, Gävle, Jönköping, Örebro, Stockholm, Sundsvall, Umeå, Västerås
2023-10-24
Recruiting
Patient Acuity in Somatic In-patient Care
NCT06035705Work Related Stress
Region Gävleborg
Observational
250
Gävle
2023-09-30
Active, closed
Ultimaster Nagomi™ Sirolimus Eluting Coronary Stent System in Complex PCI Patients
NCT05705973Cardiovascular Disease, Coronary Artery Occlusion, Ischemic Heart Disease
Terumo Europe N.V.
Observational
3,000
Gävle, Huddinge
2023-04-25
Recruiting
Region Skane
Not applicable
1,350
Borås, Eskilstuna, Gävle, Gothenburg, Halmstad, Jönköping, Kalmar, Karlstad
2023-03-17
Active, closed
AstraZeneca
Phase 3
1,350
Gävle, Linköping, Lund, Stockholm, Uppsala
2022-12-29
Active, closed
EVOLVE-MI: EVOLocumab Very Early After Myocardial Infarction
NCT05284747Cardiovascular Disease, Myocardial Infarction, Stroke, Coronary Revascularization
DrugsRepatha·Evolocumab
Amgen
Phase 4
6,019
Alingsås, Gävle, Jönköping, Karlskrona, Linköping, Luleå, Lund, Molndahl
2022-10-26
Active, closed
Region Västerbotten
Phase 4
212
Eskilstuna, Falun, Gävle, Luleå, Öre, Östersund, Skövde, Stockholm
2022-04-28
Recruiting
Sahlgrenska University Hospital
Observational
4,000
Alingsås, Bäckefors, Bollnäs, Eksjö, Enköping, Gävle, Gothenburg, Helsingborg
2022-04-26
Active, closed
HELicobacter Pylori Screening to Prevent Gastrointestinal Bleeding in Patients With Acute Myocardial Infarction
NCT05024864Myocardial Infarction, Helicobacter Pylori Infection, GastroIntestinal Bleeding, Cardiovascular Diseases
Karolinska Institutet
Not applicable
20,000
Borås, Eskilstuna, Falun, Gävle, Gothenburg, Halmstad, Helsingborg, Jönköping
2021-11-17
Active, closed
Region Örebro County
Not applicable
229
Gävle, Örebro, Västerås
2021-10-01
Recruiting
Alexander Valdman
Not applicable
254
Stockholm, Gävle, Gothenburg, Linköping, Lund, Sundsvall, Umeå, Uppsala
2021-04-20
Recruiting
Uppsala University
Not applicable
40
Gävle
2021-03-01
Active, closed
GlaxoSmithKline
Phase 2/3
758
Gävle, Stockholm, Uppsala
2020-12-08
Recruiting
Mirati Therapeutics Inc.
Phase 2/3
626
Gävle
2020-12-02
Active, closed
Remote Exercise SWEDEHEART Study
NCT04260958Myocardial Infarction
Sahlgrenska University Hospital
Not applicable
1,500
Borås, Eskilstuna, Falun, Gällivare, Gävle, Gothenburg, Hässleholm, Jönköping
2020-02-03
Active, closed
NordicTrip, a Translational Study of Preoperative Chemotherapy in TNBC
NCT04335669Breast Cancer, Triple Negative Breast Neoplasms
Lund University Hospital
Phase 3
325
Kristianstad, Borås, Gävle, Gothenburg, Halmstad, Jönköping, Karlstad, Malmö
2019-12-20
Recruiting
Uppsala University
Not applicable
1,440
Uppsala, Alingsås, Borås, Falun, Gävle, Gothenburg, Jönköping, Kalmar
2019-09-16
Recruiting
Lund University Hospital
Not applicable
100
Gävle, Gothenburg, Jönköping, Karlstad, Linköping, Lund, Örebro, Stockholm
2019-01-22
Active, closed
Norwegian University of Science and Technology
Phase 2
212
Gävle, Gothenburg, Linköping, Lund, Örebro, Stockholm
2018-07-31
Recruiting
Jeanette Lundin
Phase 1/2
50
Falun, Gävle, Lund, Gothenburg, Örebro, Stockholm, Umeå, Uppsala
2018-02-23
Recruiting
Uppsala University
Not applicable
1,300
Borås, Eskilstuna, Falun, Gävle, Gothenburg, Helsingborg, Jönköping, Kalmar
2017-06-08
Active, closed
Bypass Equipoise Sleeve Trial (BEST)
NCT02767505Severe Obesity
Göteborg University
Not applicable
1,752
Falun, Gävle, Gothenburg, Kalmar, Lindesberg, Linköping, Ljungby, Lycksele
2015-09
Active, closed
Alliance Foundation Trials, LLC.
Phase 3
5,796
Gävle, Gothenburg, Örebro, Stockholm, Uppsala
2015-08
Active, closed
Karolinska Institutet
Not applicable
2,766
Gävle, Gothenburg, Halmstad, Helsingborg, Jönköping, Kalmar, Karlskrona, Karlstad
2015-01-27
Active, closed
Eli Lilly and Company
Phase 3
493
Gävle, Örebro, Västerås
2014-11-06
Active, closed
Norwegian University of Science and Technology
Not applicable
177
Gävle, Gothenburg, Lund, Örebro, Stockholm, Umeå
2014-07-08
Active, closed
University Medical Center Groningen
Phase 3
920
Borås, Eskilstuna, Falun, Gävle, Gothenburg, Kalmar, Karlstad, Linköping
2011-06-21
Active, closed
Karolinska University Hospital
Phase 3
2,017
Gävle, Gothenburg, Karlstad, Linköping, Lund, Malmö, Örebro, Stockholm
2007-02
Rows per page Showing 1–53 of 53
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Swedish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-sweden/city/g-vle

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Sweden and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,219 studies in total at the last sync on 12 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 53 of those studies with a site in Gävle.

How many clinical trials are recruiting in Gävle?

27 of the 53 studies on this page are recruiting new participants as of the 12 Oct 2026, 03:19 UTC sync. A further 5 have not yet opened recruitment, 21 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Gävle), 53 studies
PhaseStudiesRecruitingShare
Phase 320937.7%
Not applicable16930.2%
Observational9517%
Phase 2/3325.7%
Phase 2213.8%
Phase 4203.8%
Phase 1/2111.9%

Most active sponsors

Lead sponsors with the most studies (Gävle)
Lead sponsorStudiesRecruiting
Uppsala University55
Karolinska Institutet31
Lund University Hospital32
Region Gävleborg32
University of Gavle30
Amgen21
AstraZeneca20
Bristol-Myers Squibb22
GlaxoSmithKline20
Norwegian University of Science and Technology20
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.